| Trial registration number
|
IRCT20190717044241N3 |
Full text link
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/52820
|
First author
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr. Akbar Borandegi
|
Contact
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
info@bpharmed.com
|
Registration date
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2020-12-31
|
Recruitment status
Last imported at : May 22, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Persistent hypoxemia despite receiving less than 93% Saturation oxygen
Respiratory failure requires a Ventilator
Chest has multilobar infiltrates
|
Exclusion criteria
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patient dissatisfaction
Pregnant patient
Age under 18 years and over 65 years
Patient with known active malignancy
Shock
Organ failure
|
Number of arms
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Barakat Pharmaceutical Group
|
Inclusion age min
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
65
|
Countries
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Critical disease at enrollment
|
Severity scale
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
8: Critical disease at enrollment
|
Total sample size
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
20
|
primary outcome
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Clinical response
O2 saturation
|
Notes
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 2
|
Arms
Last imported at : Jan. 1, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 787, "treatment_name": "Mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|